Bristol-Myers Squibb Company (BMY) Shareholder/Analyst Call Transcript

Core Insights - Bristol-Myers Squibb is focusing on advancements in hematology treatments, which are expected to significantly impact patient care and the company's future [2][3]. Company Overview - The conference call is led by Kate Bender from Investor Relations, highlighting the company's commitment to discussing key programs in hematology [2]. - Cristian Massacesi, the Chief Medical Officer, will present the company's slide presentation, followed by a Q&A session with other leaders in the organization [3]. Future Plans - The company will provide forward-looking statements regarding its future plans and prospects, acknowledging that actual results may vary due to various factors [4].